In Memoriam: Frans Herwig Jansen

On 3 June 2013, we lost a great Belgium doctor, an inspiring malaria professional, and a wonderful person. Mr Frans Herwig Jansen passed away at the age of 71 years.

Doctor of Medicine-Internist

Doctor of Chemistry

Founder of Dafra Pharma nv

Member of the Royal Society of Tropical Medicine

Member of the American Society of Tropical Medicine

Member of the Golf & Country Club Rinkven

Member of the Warande

Knight of the Order of Leopold

Mr Jansen was committed to malaria research through the production and refinement of Artemisinin derivatives as President of Dafra Pharma.

Read some of his publications on malaria:

Open Access | Commentary: Intermittent preventive therapy for malaria: arguments in favour of artesunate and sulphamethoxypyrazine - pyrimethamine combination
Open Access | Commentary: The pharmaceutical death-ride of dihydroartemisinin
In vitro activity of new artemisinin derivatives against Plasmodium falciparum clinical isolates from Gabon
Open Access | Stability-indicating HPLC-DAD/UV-ESI/MS impurity profiling of the anti-malarial drug lumefantrine
Open Access | An open randomized clinical trial in comparing two artesunate-based combination treatments on Plasmodium falciparum malaria in Nigerian children: artesunate/sulphamethoxypyrazine/pyrimethamine versus artesunate/amodiaquine

Frans Herwig Jansen will be remembered in our daily battle to conquer one of the greatest health challenges of our time.

The MalariaWorld team wishes his wife, children, relatives, friends, and colleagues all the love and strength they need.

Search form

You are here

In Memoriam: Frans Herwig Jansen